ID
19242
Description
NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains Book 3/Visit 3.
Keywords
Versions (3)
- 9/14/16 9/14/16 -
- 10/2/16 10/2/16 -
- 12/14/16 12/14/16 -
Uploaded on
December 14, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
M.Alzheimer GSK - Book 3 NCT00334568/ GSK-AVA100193
M.Alzheimer GSK - Book 3 NCT00334568/ GSK-AVA100193
- StudyEvent: ODM
Description
Vital Signs
Alias
- UMLS CUI-1
- C0518766
Description
Weight
Data type
float
Measurement units
- kg
Alias
- UMLS CUI [1]
- C0005910
Description
Blood pressure and heart rate will be measured once, after the subject sits quietly for at least 5 minutes.
Data type
integer
Alias
- UMLS CUI [1]
- C0871470
Description
Diastolic Blood Pressure
Data type
integer
Measurement units
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Description
Heart Rate
Data type
integer
Measurement units
- bpm
Alias
- UMLS CUI [1]
- C0018810
Description
Concomitant Medications
Alias
- UMLS CUI-1
- C2347852
Description
Adverse Events
Alias
- UMLS CUI-1
- C0877248
Description
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Description
Pedal Oedema
Alias
- UMLS CUI-1
- C0574002
Description
End of visit reminder
Alias
- UMLS CUI-1
- C1709896
- UMLS CUI-2
- C1320303
Similar models
M.Alzheimer GSK - Book 3 NCT00334568/ GSK-AVA100193
- StudyEvent: ODM
C0678257 (UMLS CUI [1,2])
C1442085 (UMLS CUI [1,2])